2-Butenoic acid,2-methyl-,(1S,2S,4aS,6aS,8R,10aR,11aS,13S)-6a-[(acetyloxy)methyl]-2,3,4,4a,6,6a,7,8,11,11a-decahydro-11a-hydroxy-1,2,9-trimethyl-6-oxo-1H-8,10a-epoxy-1,10-methanodibenz[b,e]oxepin-13-ylester, (2E)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-J9E7 |
| Product Name: | 2-Butenoic acid,2-methyl-,(1S,2S,4aS,6aS,8R,10aR,11aS,13S)-6a-[(acetyloxy)methyl]-2,3,4,4a,6,6a,7,8,11,11a-decahydro-11a-hydroxy-1,2,9-trimethyl-6-oxo-1H-8,10a-epoxy-1,10-methanodibenz[b,e]oxepin-13-ylester, (2E)- (9CI) |
| CAS: | 190719-02-9 |
| MW: | |
| Synonyms: | 2-Butenoicacid, 2-methyl-,6a-[(acetyloxy)methyl]-2,3,4,4a,6,6a,7,8,11,11a-decahydro-11a-hydroxy-1,2,9-trimethyl-6-oxo-1H-8,10a-epoxy-1,10-methanodibenz[b,e]oxepin-13-ylester, [1S-[1a,2b,4ab,6ab,8b,10ab,11ab,13R*(Z)]]-; Ligulaverin D |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |